| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 32 | 33 | 36 | 39 | 43 | 87 | 94 | 119 | 155 | 174 | 153 | 158 |
| Expenses | 25 | 27 | 30 | 33 | 34 | 53 | 50 | 57 | 75 | 91 | 81 | 86 |
| EBITDA | 6 | 6 | 6 | 6 | 10 | 34 | 44 | 62 | 80 | 83 | 71 | 73 |
| Operating Profit % | 20 % | 19 % | 17 % | 16 % | 18 % | 37 % | 45 % | 51 % | 50 % | 46 % | 46 % | 45 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 5 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | 5 | 5 | 5 | 8 | 31 | 41 | 59 | 78 | 79 | 66 | 64 |
| Tax | 0 | 0 | 1 | 1 | 2 | 8 | 11 | 15 | 20 | 20 | 17 | 14 |
| Net Profit | 5 | 5 | 4 | 4 | 6 | 24 | 30 | 44 | 58 | 59 | 49 | 48 |
| EPS in ₹ | 3.16 | 3.19 | 3.01 | 2.66 | 4.41 | 16.30 | 20.77 | 30.03 | 39.90 | 40.72 | 4.48 | 4.40 |
Gujarat Themis Biosyn
Gujarat Themis Biosyn
449.95
+0.30
(0.07%)
Q1 Quarterly Results are out. Check out the updated financials1 day ago
Show All
Key Fundamentals
Market Cap
4,899.60 Cr
EPS
4.48
PE Ratio
110.00
Dividend Yield
0.15 %
Industry
Healthcare 52 Week High
479.00
52 Week Low
208.00
PB Ratio
19.74
Debt to Equity
0.07
Sector
Pharmaceuticals Actual
Company News
View All News
Gujarat Themis Biosyn Limited announced its quarterly and half-year results ended September 30, 2025, showing total income of ₹4,234.08 lakhs for the quarter compared to ₹3,587.28 lakhs in the previous year quarter. Net profit after tax reached ₹442.64 lakhs for the quarter versus ₹306.46 lakhs in the corresponding period last year. The company appointed Mr. Rajneesh Anand as Additional Non-Executive Non-Independent Director for a five-year term effective November 10, 2025. Anand, a mechanical engineering graduate with management qualifications, has been associated with Themis Group since 1977 and serves as Director of Themis Medicare Limited. The company completed expansion of its Fermentation Block at Vapi, Gujarat, with commercial production of Rifamycin-S and Rifamycin-O commencing October 18, 2025. This expansion increased overall fermentation capacity from 450KL to 990KL, strengthening manufacturing capabilities for multiple fermentation products.
Gujarat Themis Biosyn reported a net profit of 143 million rupees in Q2, up from 106 million rupees in the same period last year. The company's EBITDA increased to 209 million rupees from 154 million rupees year-over-year. EBITDA margin improved to 49.46% compared to 44.33% in the previous year.
Gujarat Themis Biosyn Limited has started commercial production at its expanded Fermentation Block in Vapi, Gujarat. The first batch of commercial production of Rifamycin-S and Rifamycin-O commenced on October 18, 2025. The expansion has increased the company's overall fermentation capacity from 450 KL to 990 KL, more than doubling its manufacturing capabilities to produce multiple fermentation products. The company states this capacity expansion positions it to capitalize on growth opportunities in the fermentation segment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,732.10 | #1 4,11,749.90 | 39.63 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 66.26 | |
6,520.00 | 1,73,603.20 | 69.64 | 9,712.00 | 18.67 | 2,191 | 35.10 | 50.59 | |
3,824.60 | 1,29,482.50 | 60.46 | 11,539.40 | 6.99 | 1,911 | 30.46 | 70.50 | |
1,519.30 | 1,22,366.70 | 22.59 | 28,409.50 | 7.12 | 5,291 | 3.71 | 44.46 | |
1,229.60 | 1,01,113.50 | #1 17.88 | 33,741.20 | 16.73 | 5,725 | -0.38 | 47.35 | |
951.40 | 94,475.30 | 19.03 | 23,511.00 | 18.55 | 4,615 | 34.60 | 39.39 | |
2,270.00 | 91,653.00 | 52.89 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.59 | |
2,033.90 | 90,250.10 | 21.39 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 62.84 | |
5,767.50 | 68,110.20 | 29.54 | 13,458.30 | 3.70 | 2,216 | 21.39 | 70.49 | |
1,183.60 | 67,849.20 | 20.35 | 32,345.60 | 9.43 | 3,484 | 3.81 | 67.18 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-12.46 %
Net Income Growth
-17.57 %
Cash Flow Change
41.77 %
ROE
-33.15 %
ROCE
-39.54 %
EBITDA Margin (Avg.)
-2.01 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 15 | 15 | 21 | 21 | 33 | 64 | 88 | 123 | 166 | 221 | 301 |
| Fixed Assets | 10 | 9 | 11 | 11 | 15 | 17 | 19 | 19 | 33 | 38 | 41 |
| Current Assets | 4 | 3 | 8 | 8 | 8 | 29 | 63 | 78 | 62 | 48 | 52 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 13 | 21 | 91 | 184 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 5 | 5 | 11 | 10 | 17 | 47 | 67 | 90 | 113 | 92 | 76 |
| Total Liabilities | 15 | 15 | 21 | 21 | 33 | 64 | 88 | 123 | 166 | 221 | 301 |
| Current Liabilities | 10 | 9 | 12 | 8 | 13 | 17 | 16 | 17 | 15 | 16 | 21 |
| Non Current Liabilities | 6 | 2 | 1 | 1 | 1 | 5 | 3 | 2 | 2 | 4 | 32 |
| Total Equity | -1 | 4 | 8 | 12 | 19 | 42 | 70 | 103 | 149 | 201 | 248 |
| Reserve & Surplus | -8 | -3 | 1 | 5 | 11 | 35 | 63 | 96 | 142 | 194 | 238 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 11 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 0 | 0 | 1 | 0 | -0 | 3 | -4 | 6 | 0 | 5 |
| Investing Activities | -0 | -1 | -3 | -1 | -6 | -3 | -2 | -30 | -20 | -55 | -112 |
| Operating Activities | 3 | 4 | 3 | 6 | 1 | 1 | 11 | 40 | 40 | 64 | 91 |
| Financing Activities | -3 | -3 | -0 | -4 | 5 | 2 | -5 | -14 | -13 | -9 | 26 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Feb 2025 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 74.99 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % | 70.86 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 1.05 % | 1.44 % | 1.49 % | 1.42 % | 0.00 % | 1.91 % | 2.51 % | 2.95 % |
| DIIs | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.02 % | 0.03 % | 0.03 % | 0.02 % | 0.82 % | 1.18 % | 1.17 % | 1.17 % | 1.16 % | 1.17 % | 1.17 % | 1.17 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 22.07 % | 21.61 % | 21.89 % | 21.64 % | 21.30 % | 21.41 % | 21.60 % | 21.85 % | 22.09 % | 22.13 % | 21.85 % | 23.40 % | 22.26 % | 21.17 % | 20.44 % | 20.12 % | 19.75 % | 19.66 % | 19.31 % | 18.72 % |
| Others | 2.90 % | 3.36 % | 3.08 % | 3.34 % | 3.67 % | 3.56 % | 3.38 % | 3.12 % | 2.90 % | 2.84 % | 3.11 % | 5.71 % | 5.00 % | 5.35 % | 6.03 % | 6.42 % | 8.22 % | 6.39 % | 6.14 % | 6.29 % |
| No of Share Holders | 10,175 | 10,158 | 12,930 | 13,059 | 13,917 | 13,830 | 14,904 | 16,550 | 16,804 | 17,373 | 19,846 | 28,655 | 29,576 | 30,280 | 31,271 | 30,934 | 30,695 | 30,673 | 28,945 | 28,319 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 0.67 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 0.15 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Nov 2021 |  Dividend | ₹ 2.00 /share | 24 Nov 2021 | 76.39 | 70.70 |
| 25 Nov 2021 | Dividend | ₹ 5.00 /share | 24 Nov 2021 | 72.72 | 70.70 |
| 31 Aug 2022 | Dividend | ₹ 4.00 /share | 29 Aug 2022 | 57.91 | 69.11 |
| 02 Dec 2022 | Dividend | ₹ 4.40 /share | 01 Dec 2022 | 118.27 | 107.17 |
| 02 Sept 2023 | Dividend | ₹ 1.00 /share | 01 Sept 2023 | 105.71 | 107.10 |
| 13 May 2023 |  Split | 1:5 | 10 Oct 2023 | 105.71 | 105.71 |
| 22 Feb 2024 | Dividend | ₹ 0.75 /share | 22 Feb 2024 | 232.97 | 227.63 |
| 16 Jul 2024 | Dividend | ₹ 0.25 /share | 15 Jul 2024 | 268.20 | 323.30 |
| 23 Jul 2024 |  Annual General Meeting | NA | 23 Jul 2024 | 268.20 | 311.07 |
| 09 Aug 2024 |  Bonus | 1:2 | 09 Aug 2024 | 327.30 | 337.70 |
| 25 Oct 2024 |  Quarterly Result Announcement | NA | 25 Oct 2024 | 324.65 | 298.95 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 299.15 | 260.50 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 314.45 | 334.05 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 363.35 | 390.95 |
| 05 Sept 2025 | Dividend | ₹ 0.67 /share | 04 Sept 2025 | 334.05 | 381.30 |
| 12 Sept 2025 | Annual General Meeting | NA | 12 Sept 2025 | 362.30 | 381.05 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 463.05 | 450.25 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Investor Presentation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Change in Management2 days ago
2 days agoResults - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 20252 days ago
2 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)2 days ago
2 days agoBoard Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 20259 days ago
9 days agoAnnouncement Under Regulation 30 (LODR) - Commencement Of Commercial Production In Our New Fermentation Plant At Vapi Gujarat.Oct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 16, 2025
Oct 16, 2025Report On Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares.Oct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Announcement Under Regulation 30- ClarificationSep 23, 2025
Sep 23, 2025Clarification sought from Gujarat Themis Biosyn LtdSep 23, 2025
Sep 23, 2025Announcement Under Regulation 30 (Updates)Sep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 12, 2025
Sep 12, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Sep 10, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2025
Aug 20, 2025Reg. 34 (1) Annual Report.Aug 19, 2025
Aug 19, 2025Annual General Meeting To Be Held On Friday 12Th September 2025Aug 19, 2025
Aug 19, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Aug 01, 2025Corporate Action- Fixes Record Date For Declaration Dividend For Financial Year 2024-25Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 01, 2025
Aug 01, 2025Un-Audited Financial Results For The Quarter Ended 30Th June 2025.Aug 01, 2025
Aug 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 1St August 2025Aug 01, 2025
Aug 01, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th June 2025Jul 26, 2025
Jul 26, 2025Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1)Jul 25, 2025
Jul 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 13, 2025
Jun 13, 2025Announcement Under Regulation 30 Of SEBI (LODR)- Withdrawal Of Scheme Of Amalgamation.Jun 13, 2025
Jun 13, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th June 2025Jun 13, 2025
Jun 13, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Corporate Action-Board approves DividendMay 20, 2025
May 20, 2025Audited Financial Results For The Quarter And Year Ended 31St March 2025May 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 20, 2025
May 20, 2025Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2025May 15, 2025
May 15, 2025Announcement Under Regulation 30 (LODR) - UpdatesMay 06, 2025
May 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Apr 10, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Intimation Of Listing Of Equity Shares Of The Company On National Stock Exchange Of India Limited (NSE).Feb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Feb 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.11% | 3 | 0.01% | 0.02% | |
 Quant Manufacturing Fund Direct - Growth | 5.89% | 0 | 0.87% | 0.99% | |
| Quant Value Fund Direct - Growth | 0.69% | 0 | 0.09% | 0.10% |
Technical Indicators
RSI(14)
Neutral 55.75
ATR(14)
Volatile 15.51
STOCH(9,6)
Neutral 34.25
STOCH RSI(14)
Oversold 4.57
MACD(12,26)
Bearish -2.96
ADX(14)
Strong Trend 28.72
UO(9)
Bearish 41.90
ROC(12)
Downtrend And Accelerating -0.60
WillR(14)
Neutral -79.76
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
